SLU-PP-332 Test Report: What a Real COA Shows

Most arguments about purity don't start with the number on the page. They start with the blank space underneath it. A SLU-PP-332 test report claiming 99.4% purity, with no analytical method named, no lot number, and no testing laboratory identified, is a marketing asset wearing a lab coat.

Our team fields this question constantly from labs qualifying a supplier for the first time. The pattern is consistent: researchers line up purity figures from four vendors and compare percentages. Almost nobody compares methods. That's backwards, and it's the reason bad material gets through procurement.

What is a SLU-PP-332 test report?

A SLU-PP-332 test report is the batch-specific analytical record for one manufactured lot, documenting identity and purity through named methods such as HPLC and mass spectrometry, alongside the lot number, date of analysis, and testing laboratory. A report tied to no specific lot cannot be matched to the vial you receive.

There's a distinction most suppliers blur. A certificate of analysis is the one-page summary of results. A SLU-PP-332 test report, in the strict sense, includes the underlying data behind that summary: the chromatogram, the mass spectrum, the integration table. Ask for a COA and you might get a table somebody typed. Ask for the raw traces and you find out quickly whether the analysis happened at all. This piece covers what belongs on the document line by line, why peptide-style test methods are the wrong yardstick for this compound, and how verification differs between a 0.5mg and a 5mg fill.

What belongs on the document, line by line

A complete SLU-PP-332 certificate of analysis names the compound and its lot number, states the analytical method used for every result, and reports each result against a defined specification. Anything short of that is a statement of someone's confidence, not a measurement.

Start with the identity block. It should carry the compound name, the manufacturer's stated molecular formula and molecular weight, and a CAS registry number if one has been assigned to the material. Cross-check those fields against your own records before procurement. A transposed formula is the cheapest error to catch and the most expensive to discover mid-study.

Purity is where documentation usually goes soft. HPLC (high-performance liquid chromatography) separates the target compound from related substances and process impurities, and a usable SLU-PP-332 test report states the column chemistry, the mobile phase, the gradient, the detection wavelength, and the retention time of the main peak. A bare percentage without those parameters cannot be reproduced by anyone, including the vendor.

One nuance that trips up buyers: HPLC area percent and assay are not the same measurement. Area percent describes how much of the detected signal belongs to the main peak. Assay describes how much of the actual material in the vial is the compound, measured against a reference standard. A sample can read 99% area percent while carrying residual solvent and water that no UV detector will ever see.

The rest of the document should include appearance, water content by Karl Fischer titration, residual solvents by headspace gas chromatography, the analysis date, a retest date, and a signature. Our experience across supplier audits is blunt: the signature line is missing far more often than the purity line.

The method mismatch that flags a cloned certificate

SLU-PP-332 is not a peptide. It's a synthetic small-molecule pan-agonist of the estrogen-related receptors ERRalpha, ERRbeta and ERRgamma, orphan nuclear receptors that partner with the transcriptional coactivator PGC-1alpha to regulate genes governing mitochondrial biogenesis and oxidative metabolism. The compound originated in academic medicinal chemistry work at Saint Louis University, which is where the SLU prefix comes from.

That single fact decides which lines on a SLU-PP-332 test report carry meaning. Peptide certificates routinely list net peptide content, TFA (trifluoroacetic acid) counterion content, amino acid analysis, and sequence confirmation by MS/MS fragmentation. None of those apply to a small molecule. If any of them appear on a SLU-PP-332 test report, the document was cloned from a peptide template, and every number on it deserves zero trust.

The failure we see most often isn't a forged figure. It's a genuine certificate for an entirely different product class with the compound name swapped into the header. Nobody catches it, because almost everybody reads the purity line and stops reading.

What should be there instead? HPLC with UV or diode-array detection for purity, LC-MS or high-resolution mass spectrometry comparing observed mass to theoretical mass, and proton NMR for structural confirmation. NMR matters more here than buyers realise. Two different compounds can share a molecular weight. They cannot share a proton spectrum. Mass alone confirms that something of the right size is present; the spectrum confirms it's the right molecule.

ERR agonism as a metabolic research target is still early-stage science, and the literature reports pharmacokinetic limitations for this compound that have pushed medicinal chemistry toward newer analogs.

Why 0.5mg and 5mg fills get checked differently

The analytical methods don't change with fill size. The fill-weight tolerance does, and that arithmetic bites hardest at the small end. A weighing deviation of 0.05mg represents 10% of a SLU-PP-332 0.5mg vial and 1% of a SLU-PP-332 5mg vial. So the line you scrutinise on a SLU-PP-332 test report for a small fill is the stated fill weight and how it was verified, not the purity percentage you already trusted.

Small fills exist for a reason. Receptor binding work and reporter-gene assays consume microgram quantities, and a 0.5mg vial lets a lab confirm identity, solubility behaviour and assay response without committing budget to material that will sit past its retest date. The 5mg format suits multi-arm in vitro programs and concentration-response work in cell culture, where a single format keeps every well traceable to one lot.

Here's something suppliers rarely warn buyers about: 0.5mg of solid material can be visually indistinguishable from an empty vial, and static will lift it onto the walls or the stopper. The certificate's stated fill weight and gravimetric verification are what confirm contents. Eyesight isn't.

Everything downstream of that is concentration arithmetic, and mg per mL is where we stop. 5mg of compound in 1 mL of solvent gives 5 mg/mL; the same 5mg in 5 mL gives 1 mg/mL. Real Peptides does not provide dosing, administration or preparation guidance for SLU-PP-332, because it is supplied strictly as a research-use-only compound and is not an approved drug for human or veterinary use. This article is educational material for laboratory professionals, and study design, handling and safety decisions belong to the qualified investigator working under their institution's protocols. You'll also see the compound written as slu pp 332 without hyphens on some vendor listings; it's the same material, and the hyphenated form is canonical.

SLU-PP-332 Test Report Tiers: What Each Document Proves

Not all paperwork carries equal weight, and the gap matters most when you're qualifying a supplier you've never bought from. This table sets out what each tier of documentation genuinely establishes about the vial in front of you.

What If: Certificate and Vial Scenarios

What if the certificate I received isn't lot-specific?

Request the document that references the lot number printed on your vial, and treat the generic version as unusable until it arrives. A representative certificate tells you a batch somewhere passed testing, which has no bearing on the material you're holding. Suppliers running genuine batch testing can produce the lot-matched file within a day, because it already exists in their records. Suppliers who can't produce it usually aren't testing per batch at all.

What if the report lists net peptide content or amino acid analysis?

Stop and query it before the material enters any assay. Those two lines are exclusive to peptide analytics and cannot be generated for a small molecule, so their presence on a SLU-PP-332 test report means the header was edited on someone else's document. The purity figure alongside them may belong to an entirely different compound. This is the single clearest documentation red flag in this product category.

What if my 0.5mg vial looks empty?

Check the certificate's stated fill weight rather than trusting the naked eye. Half a milligram of solid compound occupies almost no visible volume, and static charge routinely carries it onto the vial wall or the underside of the stopper. Gravimetric verification against the tare weight is the only reliable confirmation. Labs that report missing product on small fills are, in our experience, almost always looking at material they cannot see.

What if the purity is listed as greater than 99% with no method named?

Treat the figure as unverified and ask which technique produced it. A percentage without a column, mobile phase, gradient and detection wavelength cannot be reproduced or challenged, which makes it an opinion formatted as data. Reputable analytics always travel with method parameters, because the parameters are what let a second laboratory confirm the first one's work.

The Unglamorous Truth About Purity Percentages

Here's the honest answer: the purity percentage is the least informative line on a SLU-PP-332 test report. It's a single number, trivially easy to type, and effectively impossible to disprove without the underlying chromatogram. The lines that actually protect your experiment are the boring ones. Lot number. Method parameters. Analysis date. Testing laboratory. Retest date. Signature. Vendors compete on percentages because percentages are cheap to claim, and researchers reward them for it by shopping on that number alone. Read the document from the bottom up and the ranking of suppliers changes fast.

Our published analytics sit alongside the catalog listing for SLU-PP-332, and lot-referenced documentation across the wider range is available in our COA library. Researchers scoping small-molecule work can review the oral research compounds collection, browse the full catalog, or check supplier details on our company page.

A SLU-PP-332 test report is, in the end, a test of the supplier rather than the compound. Anybody can print a number. Far fewer will hand over the chromatogram, the lot reference and the analysis date without being asked twice. ERR agonism is early enough in its research life that the published literature is thin, and a mislabelled batch doesn't just waste money, it costs you an experiment you can't cleanly repeat or explain. Read the method line first. The percentage will still be sitting there when you get to it.